Growth hormone treatment in the United States: Demographic and diagnostic features of 2331 children

Gilbert P. August, Barbara M. Lippe, Sandra L. Blethen, Ronald (Ron) Rosenfeld, Steven A. Seelig, Ann J. Johanson, Peter G. Compton, James W. Frane, Barbara H. McClellan, Barry M. Sherman

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Demographic, diagnostic, and baseline clinical data were collected for a large cohort (N=2331) of children who started treatment with biosynthetic human growth hormone (GH) between October 1985 and October 1987. Eighty-one percent met classic criteria for GH deficiency and were classified as having idiopathic GH deficiency (59%), organic GH deficiency (18%), or septo-optic dysplasia (4%). The remaining 19.8% had short stature of varied causes. Height standard deviation score at diagnosis, maximum GH responce to stimulation, and heights of parents were examined according to gender, race, age at diagnosis, and previous treatment history. The predominance of boys in all subgroups except septooptic dysplasia, and the observation that girls with idiopathic GH deficiency were comparatively shorter than boys at diagnosis, suggest ascertainment bias. Black children with idiopathic GH deficiency were shorter than white children at diagnosis, and their low overall representation (6.0%) compared with their percentage in the at-risk population (12.9%) also suggest ascertainment bias among races. These data provide a profile of GH deficiency as it is currently defined and expose possible inherent biases in the diagnostic process. Now that GH supply is no longer limited, criteria for its use should be formulated to avoid apparent underascertainment or late diagnosis of GH deficiency in girls and black children.

Original languageEnglish (US)
Pages (from-to)899-903
Number of pages5
JournalThe Journal of Pediatrics
Volume116
Issue number6
DOIs
StatePublished - 1990
Externally publishedYes

Fingerprint

Growth Hormone
Demography
Septo-Optic Dysplasia
Therapeutics
Human Growth Hormone
Delayed Diagnosis
Parents
History

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

August, G. P., Lippe, B. M., Blethen, S. L., Rosenfeld, R. R., Seelig, S. A., Johanson, A. J., ... Sherman, B. M. (1990). Growth hormone treatment in the United States: Demographic and diagnostic features of 2331 children. The Journal of Pediatrics, 116(6), 899-903. https://doi.org/10.1016/S0022-3476(05)80647-X

Growth hormone treatment in the United States : Demographic and diagnostic features of 2331 children. / August, Gilbert P.; Lippe, Barbara M.; Blethen, Sandra L.; Rosenfeld, Ronald (Ron); Seelig, Steven A.; Johanson, Ann J.; Compton, Peter G.; Frane, James W.; McClellan, Barbara H.; Sherman, Barry M.

In: The Journal of Pediatrics, Vol. 116, No. 6, 1990, p. 899-903.

Research output: Contribution to journalArticle

August, GP, Lippe, BM, Blethen, SL, Rosenfeld, RR, Seelig, SA, Johanson, AJ, Compton, PG, Frane, JW, McClellan, BH & Sherman, BM 1990, 'Growth hormone treatment in the United States: Demographic and diagnostic features of 2331 children', The Journal of Pediatrics, vol. 116, no. 6, pp. 899-903. https://doi.org/10.1016/S0022-3476(05)80647-X
August, Gilbert P. ; Lippe, Barbara M. ; Blethen, Sandra L. ; Rosenfeld, Ronald (Ron) ; Seelig, Steven A. ; Johanson, Ann J. ; Compton, Peter G. ; Frane, James W. ; McClellan, Barbara H. ; Sherman, Barry M. / Growth hormone treatment in the United States : Demographic and diagnostic features of 2331 children. In: The Journal of Pediatrics. 1990 ; Vol. 116, No. 6. pp. 899-903.
@article{1eaef5f65424464db3562dba231854f0,
title = "Growth hormone treatment in the United States: Demographic and diagnostic features of 2331 children",
abstract = "Demographic, diagnostic, and baseline clinical data were collected for a large cohort (N=2331) of children who started treatment with biosynthetic human growth hormone (GH) between October 1985 and October 1987. Eighty-one percent met classic criteria for GH deficiency and were classified as having idiopathic GH deficiency (59{\%}), organic GH deficiency (18{\%}), or septo-optic dysplasia (4{\%}). The remaining 19.8{\%} had short stature of varied causes. Height standard deviation score at diagnosis, maximum GH responce to stimulation, and heights of parents were examined according to gender, race, age at diagnosis, and previous treatment history. The predominance of boys in all subgroups except septooptic dysplasia, and the observation that girls with idiopathic GH deficiency were comparatively shorter than boys at diagnosis, suggest ascertainment bias. Black children with idiopathic GH deficiency were shorter than white children at diagnosis, and their low overall representation (6.0{\%}) compared with their percentage in the at-risk population (12.9{\%}) also suggest ascertainment bias among races. These data provide a profile of GH deficiency as it is currently defined and expose possible inherent biases in the diagnostic process. Now that GH supply is no longer limited, criteria for its use should be formulated to avoid apparent underascertainment or late diagnosis of GH deficiency in girls and black children.",
author = "August, {Gilbert P.} and Lippe, {Barbara M.} and Blethen, {Sandra L.} and Rosenfeld, {Ronald (Ron)} and Seelig, {Steven A.} and Johanson, {Ann J.} and Compton, {Peter G.} and Frane, {James W.} and McClellan, {Barbara H.} and Sherman, {Barry M.}",
year = "1990",
doi = "10.1016/S0022-3476(05)80647-X",
language = "English (US)",
volume = "116",
pages = "899--903",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Growth hormone treatment in the United States

T2 - Demographic and diagnostic features of 2331 children

AU - August, Gilbert P.

AU - Lippe, Barbara M.

AU - Blethen, Sandra L.

AU - Rosenfeld, Ronald (Ron)

AU - Seelig, Steven A.

AU - Johanson, Ann J.

AU - Compton, Peter G.

AU - Frane, James W.

AU - McClellan, Barbara H.

AU - Sherman, Barry M.

PY - 1990

Y1 - 1990

N2 - Demographic, diagnostic, and baseline clinical data were collected for a large cohort (N=2331) of children who started treatment with biosynthetic human growth hormone (GH) between October 1985 and October 1987. Eighty-one percent met classic criteria for GH deficiency and were classified as having idiopathic GH deficiency (59%), organic GH deficiency (18%), or septo-optic dysplasia (4%). The remaining 19.8% had short stature of varied causes. Height standard deviation score at diagnosis, maximum GH responce to stimulation, and heights of parents were examined according to gender, race, age at diagnosis, and previous treatment history. The predominance of boys in all subgroups except septooptic dysplasia, and the observation that girls with idiopathic GH deficiency were comparatively shorter than boys at diagnosis, suggest ascertainment bias. Black children with idiopathic GH deficiency were shorter than white children at diagnosis, and their low overall representation (6.0%) compared with their percentage in the at-risk population (12.9%) also suggest ascertainment bias among races. These data provide a profile of GH deficiency as it is currently defined and expose possible inherent biases in the diagnostic process. Now that GH supply is no longer limited, criteria for its use should be formulated to avoid apparent underascertainment or late diagnosis of GH deficiency in girls and black children.

AB - Demographic, diagnostic, and baseline clinical data were collected for a large cohort (N=2331) of children who started treatment with biosynthetic human growth hormone (GH) between October 1985 and October 1987. Eighty-one percent met classic criteria for GH deficiency and were classified as having idiopathic GH deficiency (59%), organic GH deficiency (18%), or septo-optic dysplasia (4%). The remaining 19.8% had short stature of varied causes. Height standard deviation score at diagnosis, maximum GH responce to stimulation, and heights of parents were examined according to gender, race, age at diagnosis, and previous treatment history. The predominance of boys in all subgroups except septooptic dysplasia, and the observation that girls with idiopathic GH deficiency were comparatively shorter than boys at diagnosis, suggest ascertainment bias. Black children with idiopathic GH deficiency were shorter than white children at diagnosis, and their low overall representation (6.0%) compared with their percentage in the at-risk population (12.9%) also suggest ascertainment bias among races. These data provide a profile of GH deficiency as it is currently defined and expose possible inherent biases in the diagnostic process. Now that GH supply is no longer limited, criteria for its use should be formulated to avoid apparent underascertainment or late diagnosis of GH deficiency in girls and black children.

UR - http://www.scopus.com/inward/record.url?scp=0025302088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025302088&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(05)80647-X

DO - 10.1016/S0022-3476(05)80647-X

M3 - Article

C2 - 2348293

AN - SCOPUS:0025302088

VL - 116

SP - 899

EP - 903

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 6

ER -